# Association of NK cells with a shift in tryptophan catabolism in patients with heart failure after a single exercise exertion

**Authors:** Krithika Swaminathan, Bita Astan, Sabine Kaczmarek, Kristin Lehnert, Anke Hannemann, Aycen Koc, Nele Friedrich, Kathrin Budde, Ann-Kristin Henning, Grażyna Domańska, Ulf Landmesser, Christian Templin, Marcus Dörr, Martin Bahls, Nicolle Kränkel

PMC · DOI: 10.3389/fimmu.2025.1732461 · Frontiers in Immunology · 2026-01-26

## TL;DR

This study shows that exercise in heart failure patients increases tryptophan metabolism via NK cells, linked to immune and energy changes.

## Contribution

The study provides new mechanistic evidence that IL-12 induces a shift in NK cell function and tryptophan metabolism in heart failure patients after exercise.

## Key findings

- Exercise in HFrEF patients leads to increased KYN production and QUIN accumulation via NK cells.
- IL-12 exposure shifts NK cell phenotype and boosts TRP metabolism into KYN.
- Non-NK cells also show increased TRP-KYN flux and QUIN formation when exposed to IFN-γ.

## Abstract

Tryptophan (TRP) metabolism via the kynurenine (KYN) pathway links immune function, energy metabolism, and redox homeostasis. Dysregulation of this pathway has been implicated in inflammatory conditions and heart failure. Here, we investigated the acute effects of exercise on TRP-KYN metabolism and its relationship with natural killer (NK) cell function in controls and patients with heart failure with reduced ejection fraction (HFrEF).

Control (n=13) and HFrEF (n=16) groups had comparable composition regarding age and sex. Participants were investigated at baseline, immediately after a maximal symptom-limited cardiopulmonary exercise test (CPET), and after 2 hours of resting. Blood samples were obtained at all time points to assess NK cell counts and phenotypic parameters by flow cytometry, as well as tryptophan metabolites and protein secretome by mass spectrometry and targeted proteomics, respectively. NK cells and non-NK cells from blood of healthy donors were stimulated ex vivo prior to flow cytometry-based measurement, indoleamine 2,3-dioxygenase (IDO) mRNA expression analysis and mass spectrometry-based tryptophan metabolite analysis.

Plasma TRP levels decreased post-exercise in both study groups, with increased metabolism down the KYN route, albeit only in HFrEF patients, a significant accumulation of quinolinate (QUIN) was seen. Increases in plasma KYN-to-TRP ratios correlated with more circulating NK cell counts and IL-12p70 levels mainly in the HFrEF group. Ex vivo, IL-12 exposure of human total primary NK cells increased representation of the CD56-bright subset, IDO mRNA expression, and TRP-to-KYN conversion, resulting in net KYN accumulation and elevated QUIN production. In non-NK cells, IFN-γ exposure similarly promoted TRP-to-KYN flux and QUIN formation.

Collectively, our observations confirm earlier descriptive reports of exercise-induced upregulation of KYN production by NK cells and add mechanistic evidence that IL-12 induces a phenotype shift in NK cells, which is accompanied by accelerated TRP metabolism into KYN. Our data point to a concerted interaction between leukocyte subsets upon acute exercise, via the release of IL-12, with potential implications for differential energy metabolism and immune regulation in HFrEF.

Flowchart depicting a process starting with two groups: Control and HFrEF, undergoing CPET. This leads to the release of IL-12, causing NK phenotype and secretome changes. It also induces release of NK cells and a TRP metabolism shift in NK and non-NK cells.

## Linked entities

- **Proteins:** IDO1 (indoleamine 2,3-dioxygenase 1), IFNG (interferon gamma)
- **Chemicals:** tryptophan (PubChem CID 1148), kynurenine (PubChem CID 846), quinolinate (PubChem CID 1066)
- **Diseases:** heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, IDO1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 3620] {aka IDO, IDO-1, INDO}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** inflammatory (MESH:D007249), heart failure (MESH:D006333)
- **Chemicals:** TRP (MESH:D014364), KYN (MESH:D007737), QUIN (MESH:D017378)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883804/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12883804/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883804/full.md

---
Source: https://tomesphere.com/paper/PMC12883804